By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Gastric bypass surgery, also known as Roux-en-Y gastric bypass, is a surgical procedure performed to help individuals with severe obesity lose weight by altering the anatomy of the digestive system. During the procedure, a small pouch is created at the top of the stomach and connected directly to the small intestine, bypassing a portion of the stomach and the upper part of the small intestine.
This reconfiguration of the digestive tract restricts the amount of food that can be consumed and reduces the absorption of nutrients, leading to weight loss. Gastric bypass surgery is typically recommended for individuals with a body mass index (BMI) of 40 or higher, or a BMI of 35 or higher with obesity-related health conditions such as type 2 diabetes, hypertension, or obstructive sleep apnea.
The procedure can be performed using minimally invasive techniques, such as laparoscopy, which involves making small incisions in the abdomen and using specialized instruments to perform the surgery. Gastric bypass surgery is considered one of the most effective treatments for severe obesity, resulting in significant and sustained weight loss, improvement in obesity-related health conditions, and enhanced quality of life for many patients.
However, gastric bypass surgery is not without risks, and it requires a lifelong commitment to dietary and lifestyle changes to maintain weight loss and prevent complications. Patients undergoing gastric bypass surgery typically undergo thorough preoperative evaluation, including medical assessment, nutritional counseling, and psychological evaluation, to ensure they are suitable candidates for the procedure and to optimize outcomes.
Global gastric bypass surgery devices accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
In January 2022, Spatz3 launched its FDA-approved product, Spatz3 Adjustable Balloon System, for treating obesity and producing weight loss results without micronutrient deficiencies.
September 2022, Allurion Technologies, a US-based medical device maker, launched a swallowable gastric balloon in India for weight loss. The Allurion Balloon is a soft polyurethane capsule that contains a deflated balloon. During a 15-minute clinic visit, a patient swallows the capsule, and a healthcare professional uses a catheter to inflate the balloon with 550 milliliters of fluid.
In January 2023, SlimFit Surgical Solutions launched an advanced robotic-assisted surgical system for bariatric procedures.